BIM
LFCR icon

BlackRock Investment Management’s Lifecore Biomedical LFCR Stock Holding History

BlackRock Investment Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.55M Sell
112,044
-1,092
-1% -$15.1K ﹤0.01% 2396
2016
Q3 		$1.52M Buy
113,136
+6,811
+6% +$82.5K ﹤0.01% 2390
2016
Q2 		$1.14M Buy
106,325
+6,651
+7% +$73.4K ﹤0.01% 2530
2016
Q1 		$1.05M Sell
99,674
-1,637
-2% -$18K ﹤0.01% 2454
2015
Q4 		$1.2M Buy
101,311
+116
+0.1% +$1.43K ﹤0.01% 2460
2015
Q3 		$1.18M Sell
101,195
-1,399
-1% -$18.5K ﹤0.01% 2480
2015
Q2 		$1.48M Buy
102,594
+13,872
+16% +$200K ﹤0.01% 2471
2015
Q1 		$1.24M Sell
88,722
-238
-0.3% -$3.29K ﹤0.01% 2384
2014
Q4 		$1.23M Sell
88,960
-464
-0.5% -$6K ﹤0.01% 2404
2014
Q3 		$1.09M Buy
89,424
+2,453
+3% +$30.6K ﹤0.01% 2463
2014
Q2 		$1.09M Buy
86,971
+15,551
+22% +$183K ﹤0.01% 2544
2014
Q1 		$797K Sell
71,420
-564
-0.8% -$6.19K ﹤0.01% 2673
2013
Q4 		$872K Sell
71,984
-1,514
-2% -$18.1K ﹤0.01% 2599
2013
Q3 		$897K Buy
73,498
+4,523
+7% +$63.1K ﹤0.01% 2526
2013
Q2 		$911K Buy
+68,975
New +$954K ﹤0.01% 2432

Other funds holding LFCR

NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Investment Management's LFCR Position: Q4 2016 in Review

BlackRock Investment Management reduced its Lifecore Biomedical (LFCR) stake by 0.97% in Q4 2016, selling an estimated $15.1K and leaving 112,044 shares worth $1.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2396.

BlackRock Investment Management first reported a position in LFCR in Q2 2013 and has held it in 15 quarters since. 93 funds tracked by Wall St. Rank hold LFCR as of Q4 2016.

  • BlackRock Investment Management held 112,044 shares of Lifecore Biomedical worth $1.55M as of Q4 2016.
  • BlackRock Investment Management sold 1,092 Lifecore Biomedical shares in Q4 2016, an estimated $15.1K.
  • Lifecore Biomedical made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2396 holding.
  • BlackRock Investment Management first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 15 quarters since.
  • 93 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.